# Daily Position Review ## Evidence boundary - Supplied: ALPH is 31% of the portfolio and is down 6.2% since yesterday. - Supplied: BETA is 18% and is up 1.4% since yesterday. - Supplied: cash is 11%; the buyer's limits are 35% maximum single position and 12% target cash. - Supplied: the buyer provided theses, one catalyst for ALPH, invalidation conditions, and time horizons. - Unknown: current prices, news, sector weights, peer comparisons, portfolio value, and whether either thesis is supported by external evidence. These remain `[UNVERIFIED]`. ## Position table | Position | Weight | Supplied change | Thesis evidence | Catalyst | Invalidation | Concentration | Time horizon | Missing information | | --- | ---: | ---: | --- | --- | --- | --- | --- | --- | | ALPH | 31% | -6.2% | Enterprise renewals should support durable revenue; supporting evidence `[UNVERIFIED]` | Results scheduled 2026-10-08 | Renewal growth below the buyer's stated plan | Largest position; peer and sector weights `[UNVERIFIED]` | 12 months | Renewal data, portfolio value, external event details `[UNVERIFIED]` | | BETA | 18% | +1.4% | Margin improvement may continue; supporting evidence `[UNVERIFIED]` | `[UNVERIFIED]` | Margin improvement reverses | Second-largest position; peer and sector weights `[UNVERIFIED]` | 6 months | Catalyst, margin data, portfolio value `[UNVERIFIED]` | ## Change log | Position | Numerical move in supplied snapshot | Thesis change | Evidence status | | --- | --- | --- | --- | | ALPH | -6.2% since yesterday | No thesis change supplied | Numerical move supplied; cause `[UNVERIFIED]` | | BETA | +1.4% since yesterday | No thesis change supplied | Numerical move supplied; cause `[UNVERIFIED]` | ## Priority review queue 1. ALPH: identify the buyer-supplied evidence that would test the renewal-growth invalidation before the 2026-10-08 results date. 2. ALPH: compare the 31% weight with the buyer's 35% limit and record whether any other position or sector makes concentration higher than this snapshot shows `[UNVERIFIED]`. 3. BETA: supply the missing catalyst and the evidence supporting the margin-improvement thesis. 4. Cash: compare the supplied 11% cash with the 12% target and record the buyer's own explanation for the difference. ## Limit check - ALPH at 31% is below the supplied 35% maximum single-position limit by 4 percentage points. - Cash at 11% is 1 percentage point below the supplied 12% target. - A full portfolio concentration check is `[UNVERIFIED]` because no other weights or sector totals were supplied. ## Scenario questions 1. What buyer-supplied renewal number would count as evidence for or against the ALPH thesis? 2. What would make the buyer classify the ALPH move as a thesis change rather than a numerical move? 3. Which BETA margin measure and time period should be compared next? 4. What additional position or sector weights are needed to complete the concentration check? ## Boundary note This is a review of the pasted material, not investment advice or a current-market report. No prices, news, ratings, or events were retrieved.